Coherus Oncology, Inc.
CHRS
$1.59
$0.010.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -129.74M | -142.80M | -118.02M | -130.94M | 28.51M |
| Total Depreciation and Amortization | 2.91M | 3.05M | 3.63M | 4.82M | 5.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.14M | 40.19M | 51.29M | 48.49M | -110.12M |
| Change in Net Operating Assets | 17.81M | 56.01M | 3.87M | 78.13M | 55.89M |
| Cash from Operations | -91.88M | -43.56M | -59.23M | 500.00K | -20.44M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.55M | -85.26M | -17.58M | 10.07M | 230.32M |
| Cash from Investing | -87.55M | -85.26M | -17.58M | 10.07M | 230.32M |
| Total Debt Issued | -- | 0.00 | -141.00K | 36.98M | 36.98M |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -260.39M | -260.39M |
| Issuance of Common Stock | 8.06M | 241.00K | 241.00K | 874.00K | 2.38M |
| Repurchase of Common Stock | -267.00K | -277.00K | -284.00K | -2.00M | -2.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.00K | 5.00K | -16.00K | 36.40M | 36.53M |
| Cash from Financing | 7.82M | -31.00K | -200.00K | -188.13M | -186.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.61M | -128.84M | -77.02M | -177.55M | 22.91M |